AlanC wrote:It seems to me that the experiment is so badly flawed that it would be very hard to draw any solid conclusions from it. It is a huge waste of time and money. I doubt if the experiment will ever get published in a reputable journal because the design of the experiment is so poor, and so it will not get through peer review.
“We were hoping that a weight-loss program would help reduce cardiovascular disease, but now we have the answer that it doesn’t,” said Mary E. Evans, a physician at the National Institute of Health’s National Institute of Diabetes and Digestive and Kidney Diseases, which paid for the study.
But the outcome is clear, said Dr. David Nathan, a principal investigator and director of the Diabetes Center at Massachusetts General Hospital. “We have to have an adult conversation about this,” he said. “This was a negative result.”
But the outcome is clear, said Dr. David Nathan, a principal investigator and director of the Diabetes Center at Massachusetts General Hospital. “We have to have an adult conversation about this,” he said. “This was a negative result.”
borofergie wrote:So it's a 55% carbohydrate diet, exactly the sort of thing advocated by the NHS and DUK.
phoenix wrote:What do we actually know?
At year eleven the trial was stopped. (this seems to be according to the procedure described in the protocol ;ie they described the circumstances that would stop the trial from the start(
This was during the follow up so by then very much reduced intervention.
there was no difference in CVD events
The 'lifestyle' (intervention) group used fewer medications than the DSE (control)group.
Overall in the lifestyle group there was a 5% reduction in weight.
“We were hoping that a weight-loss program would help reduce cardiovascular disease, but now we have the answer that it doesn’t,” said Mary E. Evans, a physician at the National Institute of Health’s National Institute of Diabetes and Digestive and Kidney Diseases, which paid for the study.
But the outcome is clear, said Dr. David Nathan, a principal investigator and director of the Diabetes Center at Massachusetts General Hospital. “We have to have an adult conversation about this,” he said. “This was a negative result.”
AlanC wrote:It seems to me that the experiment is so badly flawed that it would be very hard to draw any solid conclusions from it. It is a huge waste of time and money. I doubt if the experiment will ever get published in a reputable journal because the design of the experiment is so poor, and so it will not get through peer review.
borofergie wrote:
I hope they publish the body counts.
Defren wrote:The people who took part in this trial, possibly knew nothing about a low carb diet and diabetes, so will have gone into this trial thinking it may help them, when as we can see 11.5 years later, there is a body count. There is not a shread of doubt in my mind, had these people trialed a low carbohydrate diet, many would still be alive, AND healthy.
Defren wrote:It's this kind of thing that really concerns me. Not that you wonder if they will publish a body count Stephen, but the fact there will be one.
The only cardiovascular risk factor that remained unchanged with treatment was LDL-cholesterol levels.
This is not new, we saw it in MR FIT in 1982 found no significant CV benefit and no overall benefit from intensive lifestyle intervention. The Goteborg Study published in 1986 also demonstrated no benefit.
The Action for Health Diabetes (Look AHEAD) study, a trial comparing an intensive lifestyle-intervention program aimed at achieving and maintaining weight loss and fitness in patients with type 2 diabetes, has been stopped for futility.
A large cardiovascular-outcomes study funded by the National Institutes of Health that included 5145 adults with diabetes and a body mass index >25 kg/m2, Look AHEAD failed to show a difference in the rate of nonfatal MI, nonfatal stroke, death, or hospitalization for angina among patients randomized to an intensive lifestyle intervention and those randomized to a control arm consisting of education alone.
Despite significant reductions in weight and improvements in physical-fitness levels among patients with diabetes, investigators concluded that the intervention arm, which included individual sessions with a nutritionist and/or personal trainer, as well as group sessions and refresher courses, failed to provide any benefit in terms of cardiovascular outcomes.

borofergie wrote:Hah - got there at the same time as BlindDog:
Here is the earlier report which mentions the unchanged LDL levels:
Only those that approached 15% weight loss got anywhere near reducing their HbA1c by 1%, most were nearer to 0.5%. By comparison, I achieved a 5.7% reduction in HbA1c (for 10.6% to 4.9%) by low-carbing.
Paul JaminetOctober 22, 2012 11:39 AM
Good point about the change in weight vs outcomes, that would be interesting. Hard to say anything about this trial based on the press releases and news stories. I haven't seen any useful data yet
Stephan GuyenetOctober 23, 2012 12:46 PM
A 5% weight loss can be clinically significant even if it's not aesthetically significant. The DPP and related trials had similar weight losses and they prevented diabetes incidence by up to 60%. This was basically a follow-up study to DPP and there was every reason to believe the intervention would be effective based on previous trials.
The reason Look AHEAD was terminated early is that it was hopelessly underpowered. The event rate was nearly 4X lower than expected. It's still possible that the intervention would have been highly successful, but we'll never know because the study design turned out to be inadequate. Still, they found improvements in several secondary endpoints.
http://www.drsharma.ca/looking-back-at-look-ahead.htm
This reduction in body weight was accompanied by significant improvements in glycemic control and numerous other health benefits (e.g. decreased sleep apnea, improved mobility and quality of life)
given a remarkably low incidence of ‘hard’ endpoints in both the interventions and control groups, it became evident the the study would stand little chance of demonstrating superiority of the lifestyle intervention in terms of preventing cardiovascular complications.
Nevertheless, according to the recommendations of the Data Monitoring Board, the study should be continued (without the intervention) to determine the long-term outcomes in the participants.
Not only may future studies have to enrol a substantially greater number of participants but such studies may also need to substantially enrich the study population with higher risk individuals to increase event rates (i.e. EOSS Stage 3 rather than just EOSS Stage 2 patients).
Registered users: BexC89, Bing [Bot], daisy1, dawnmc, debbiem1, destiny, gal173, Google [Bot], Google Adsense [Bot], jddukes, lenipenny, Lucyturner, mark5745, MSN [Bot], naillig, saz1902, sugarfreehannah, sunshine1612